S&P 500 7,718.60 −0.38%
Nasdaq 26,506.99 −0.29%
S&P/TSX 36,513.80 −0.33%
Apple 319.97 −2.51%
Nvidia 230.36 +0.84%
Microsoft 499.70 −2.04%
Shopify 200.76 −0.10%
Royal Bank 291.48 −0.30%
CAD/USD 0.7233 −0.26%
CLOSED · 16:55 ET
Market ClerkRecap
Sun Sep 6 · markets closed2 signals today321 insider buys this week · $404MCIRO short report next: Sep 15The week ahead
TK
INSIDER · MNPR · Monopar Therapeutics · DIRECTOR

Tsuchimoto Kim R

Every open-market transaction filed under this name, Aug 26 to Aug 26.

Filings
6
0 buys · 6 sells
Bought
open market, at cost
Sold
$456K
includes scheduled sales
Buys since
no current price on file

Filings

SEC FORM 4 · OPEN MARKET
TradedTickerCompanyRoleTypeSharesPriceValueSince
Aug 26MNPRMonopar TherapeuticsDirectorSell590$113.84$67K−1.7%
Aug 26MNPRMonopar TherapeuticsDirectorSell602$112.93$68K−0.9%
Aug 26MNPRMonopar TherapeuticsDirectorSell1,098$111.84$123K+0.0%
Aug 26MNPRMonopar TherapeuticsDirectorSell700$110.65$77K+1.1%
Aug 26MNPRMonopar TherapeuticsDirectorSell615$109.56$67K+2.1%
Aug 26MNPRMonopar TherapeuticsDirectorSell485$108.83$53K+2.8%

"Since" is the stock's move from the filed price to the latest quote on file, not a scored call. Open-market purchases and sales only; option exercises and grants are excluded.